Does a higher response rate to systemic chemotherapy result in a higher resection rate in patients with initially unresectable colorectal liver metastases?

By Sunakawa Yu  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 1039-1040

Informa Healthcare

Access to resources Recommend Favorite

A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial

By Ychou Marc   Rivoire Michel   Thezenas Simon   Quenet François   Delpero Jean-Robert   Rebischung Christine   Letoublon Christian   Guimbaud Rosine   Francois Eric   Ducreux Michel   Desseigne Françoise   Fabre Jean-Michel   Assenat Eric  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4289-4297

Springer Publishing Company

Access to resources Recommend Favorite

Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials

By                      

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1849-1856

Spandidos Publications

Access to resources Recommend Favorite

Defining resectability of colorectal liver metastases: how and why?

By Voorthuizen Theo van   van Gulik Thomas M   Punt Cornelis JA  

Colorectal Cancer, Vol. 2, Iss. 1, 2013-02 ,pp. : 61-72

Future Medicine

Access to resources Recommend Favorite

Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence

By Mima Kosuke   Beppu Toru   Chikamoto Akira   Miyamoto Yuji   Nakagawa Shigeki   Kuroki Hideyuki   Okabe Hirohisa   Hayashi Hiromitsu   Sakamoto Yasuo   Watanabe Masayuki   Kikuchi Ken   Baba Hideo  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 847-855

Springer Publishing Company

Access to resources Recommend Favorite